Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data

被引:54
作者
Vass, Marton [1 ]
Podlewska, Sabina [2 ]
de Esch, Iwan J. P. [1 ]
Bojarski, Andrzej J. [2 ]
Leurs, Rob [1 ]
Kooistra, Albert J. [1 ,3 ]
de Graaf, Chris [1 ,4 ]
机构
[1] Vrije Univ Amsterdam, Div Med Chem, Fac Sci, AIMMS, NL-1081 HZ Amsterdam, Netherlands
[2] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Smetna 12, PL-31343 Krakow, Poland
[3] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark
[4] Sosei Heptares, Steinmetz Bldg,Granta Pk, Cambridge CB21 6DG, England
关键词
SITE-DIRECTED MUTAGENESIS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; PROTEIN-COUPLED RECEPTOR; HISTAMINE H-4 RECEPTOR; 2ND EXTRACELLULAR LOOP; SINGLE AMINO-ACID; CONSERVED SERINE RESIDUES; 5TH TRANSMEMBRANE DOMAIN; BETA-ADRENERGIC-RECEPTOR; MEMBRANE-SPANNING DOMAIN;
D O I
10.1021/acs.jmedchem.8b00836
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aminergic family of G protein-coupled receptors (GPCRs) plays an important role in various diseases and represents a major drug discovery target class. Structure determination of all major aminergic subfamilies has enabled structure based ligand design for these receptors. Site-directed mutagenesis data provides an invaluable complementary source of information for elucidating the structural determinants of binding of different ligand chemotypes. The current study provides a comparative analysis of 6692 mutation data points on 34 aminergic GPCR subtypes, covering the chemical space of 540 unique ligands from mutagenesis experiments and information from experimentally determined structures of 52 distinct aminergic receptor-ligand complexes. The integrated analysis enables detailed investigation of structural receptor-ligand interactions and assessment of the transferability of combined binding mode and mutation data across ligand chemotypes and receptor subtypes. An overview is provided of the possibilities and limitations of using mutation data to guide the design of novel aminergic receptor ligands.
引用
收藏
页码:3784 / 3839
页数:56
相关论文
共 301 条
[1]   Mechanistic Insights into Allosteric Structure-Function Relationships at the M1 Muscarinic Acetylcholine Receptor [J].
Abdul-Ridha, Alaa ;
Lane, J. Robert ;
Mistry, Shailesh N. ;
Lopez, Laura ;
Sexton, Patrick M. ;
Scammells, Peter J. ;
Christopoulos, Arthur ;
Canals, Meritxell .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (48) :33701-33711
[2]   Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor [J].
Abdul-Ridha, Alaa ;
Lopez, Laura ;
Keov, Peter ;
Thal, David M. ;
Mistry, Shailesh N. ;
Sexton, Patrick M. ;
Lane, J. Robert ;
Canals, Meritxell ;
Christopoulos, Arthur .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (09) :6067-6079
[3]   A SINGLE-POINT MUTATION INCREASES THE AFFINITY OF SEROTONIN 5-HT1D-ALPHA, 5-HT1D-BETA, 5-HT1E AND 5-HT1F RECEPTORS FOR BETA-ADRENERGIC ANTAGONISTS [J].
ADHAM, N ;
TAMM, JA ;
SALON, JA ;
VAYSSE, PJJ ;
WEINSHANK, RL ;
BRANCHEK, TA .
NEUROPHARMACOLOGY, 1994, 33 (3-4) :387-391
[4]   Mutational analysis of the α1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay [J].
Ahmed, Maruf ;
Hossain, Murad ;
Bhuiyan, Mohiuddin Ahmed ;
Ishiguro, Masaji ;
Tanaka, Takashi ;
Muramatsu, Ikunobu ;
Nagatomo, Takafumi .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (04) :598-601
[5]   Contributions of cysteine 114 of the human D3 dopamine receptor to ligand binding and sensitivity to external oxidizing agents [J].
Alberts, GL ;
Pregenzer, JF ;
Bin Im, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) :705-710
[6]   Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M1 muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine [J].
Allman, K ;
Page, KM ;
Curtis, CAM ;
Hulme, EC .
MOLECULAR PHARMACOLOGY, 2000, 58 (01) :175-184
[7]   Mapping the binding site pocket of the serotonin 5-hydroxytryptamine(2A) receptor - Ser(3.36(159)) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin [J].
Almaula, N ;
Ebersole, BJ ;
Zhang, DQ ;
Weinstein, H ;
Sealfon, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) :14672-14675
[8]  
Almaula N, 1996, MOL PHARMACOL, V50, P34
[9]   Developing Chemical Genetic Approaches to Explore G Protein-Coupled Receptor Function: Validation of the Use of a Receptor Activated Solely by Synthetic Ligand (RASSL) [J].
Alvarez-Curto, Elisa ;
Prihandoko, Rudi ;
Tautermann, Christofer S. ;
Zwier, Jurriaan M. ;
Pediani, John D. ;
Lohse, Martin J. ;
Hoffmann, Carsten ;
Tobin, Andrew B. ;
Milligan, Graeme .
MOLECULAR PHARMACOLOGY, 2011, 80 (06) :1033-1046
[10]  
Ambrosio C, 2000, MOL PHARMACOL, V57, P198